Envoy Medical (COCH) EBITDA Margin (2022 - 2026)
Envoy Medical's (COCH) quarterly EBITDA Margin came in at 11158.97% in Q1 2026, down 30680.0% year-on-year from N/an in Q1 2025, and down 27.08% quarter-over-quarter from 8781.33% in Q4 2025.
Envoy Medical (COCH) EBITDA Margin (2022 - 2026) Analysis & Trends
Envoy Medical has disclosed EBITDA Margin across 5 years of filings, most recently posting 11158.97% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 11158.97%, down 30680.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9877.35% (down 66933.0% YoY), and the FY2025 annual result was 9856.02%, down 61157.0% from the prior year.
- EBITDA Margin came in at 11158.97% for Q1 2026 at Envoy Medical, down from 8781.33% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 1952.5% in Q3 2023 to a low of 57405.0% in Q4 2022.
- The 5-year median for EBITDA Margin is 10644.64% (2024), against an average of 12838.97%.
- Across the five-year window, EBITDA Margin jumped 5225026 bps in 2023 and tumbled 1259714 bps in 2024, its largest moves.
- Envoy Medical's EBITDA Margin stood at 57405.0% in 2022, then soared by 91 bps to 5154.74% in 2023, then tumbled by 113 bps to 11000.0% in 2024, then climbed by 20 bps to 8781.33% in 2025, then fell by 27 bps to 11158.97% in 2026.
- The last three EBITDA Margin figures came in at 11158.97% (Q1 2026), 8781.33% (Q4 2025), and 15435.71% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Envoy Medical | 44.81 Mn | 19.56 Mn | -274,000.00 | -11,158.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,158.97% |
| Dec 31, 2025 | -8,781.33% |
| Sep 30, 2025 | -15,435.71% |
| Jun 30, 2025 | -7,297.44% |
| Mar 31, 2025 | -10,852.17% |
| Dec 31, 2024 | -11,000.00% |
| Sep 30, 2024 | -10,644.64% |
| Jun 30, 2024 | -5,805.88% |
| Mar 31, 2024 | -10,628.81% |
| Dec 31, 2023 | -5,154.74% |
| Sep 30, 2023 | 1,952.50% |
| Jun 30, 2023 | -21,026.98% |
| Mar 31, 2023 | -16,991.03% |
| Dec 31, 2022 | -57,405.00% |
| Sep 30, 2022 | -2,354.39% |